학술논문
CheckMate 025: a randomized, open-label, phase III study of nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
18790852